Awakn Life Sciences Announces Credit Facility
Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...
Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...
The latest episodes focus on the importance of mental health resources for the next generation of collegiate athletes ENGLEWOOD CLIFFS,...
ASPEN, Colo., Dec. 17, 2024 /PRNewswire/ -- BRAIN.ONE, a groundbreaking personalized brain fitness platform, is pleased to announce a partnership...
NORTHAMPTON, MA / ACCESSWIRE / December 17, 2024 / Quest DiagnosticsOriginally published in Quest Diagnostics' 2023 Corporate Responsibility ReportMinimizing our...
As Medical Officer, Dr. Stacy will assist in reviewing addiction and substance-abuse related research and serve as Rehab.com's spokesperson and...
Foundation Supports 144 Organizations to Champion Human-Centered AI with Capital, AI Expertise, and a Commitment to Inclusive Global AI.BOSTON--(BUSINESS WIRE)--#AIInnovation--Artificial...
Foundation Supports 144 Organizations to Champion Human-Centered AI with Capital, AI Expertise, and a Commitment to Inclusive Global AI.BOSTON--(BUSINESS WIRE)--#AIInnovation--Artificial...
NEW YORK, Dec. 17, 2024 /PRNewswire/ -- Today, the Ad Council, America's leading nonprofit driving social change through the power of...
Mark Khavkin appointed to Chief Financial Officer (CFO) and Prashanthi Raman to Chief External Affairs Officer (CEAO) LOS ANGELES, Dec....
Secondary analysis of a randomized, placebo-controlled study of 1,000+ participants indicated that FDA-authorized RelieVRx® yielded clinically meaningful pain intensity and pain...
World Health Organization (WHO) has classified the global resurgence of cholera at the highest internal level for emergencies; 1.3 to...
Patient screening underway; first patient expected to be randomized into the study in January A leading clinical trial site management...
Agreement Supports Phase IIb and Future Phase III Trial Development,Addressing Critical Needs in Palliative Care Using Optimi's Natural Psilocybin ExtractVancouver,...
Ottawa, Ontario--(Newsfile Corp. - December 16, 2024) - The Canadian Counselling and Psychotherapy Association (CCPA) has long recognized the critical...
HUNTSVILLE, Ala., Dec. 16, 2024 /PRNewswire/ -- iXpressGenes (iXG), a biotechnology company transforming trauma care, is proud to appoint co-founder...
Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the...
Brian Scherner shares his perspective on community health in new online feature. PORTLAND, OR / ACCESSWIRE / December 16, 2024...
NEW YORK, Dec. 15, 2024 /PRNewswire/ -- The global online therapy services market size is estimated to grow by USD 16.16 billion...
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a survey on nicotine use...
Crofelemer is the subject of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies -...